Bottle Label 15 mg (71610 0497 60)
Pioglitazone Hydrochloride
Product Images NDC 71610-497
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone Hydrochloride (NDC 71610-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 Shows The Time Course For Changes In Hba1c In This 26-week Study (Pioglitazone Fig1)
The text describes a graph titled "Mean Change from Baseline for HbAlc in a 26-Week Placebo-Controlled Dose-Ranging Study". The graph shows the observed mean values for the study over the course of 26 weeks, with the x-axis representing the weeks and the y-axis representing percent change. It appears that there are three different treatment groups represented by different doses (15mg, 30mg, and 45mg).*
Chemical Structure (Pioglitazone Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
